MP
MaaT Pharma Microbiota as a Therapy is a French biotech startup focused on developing microbiota-based therapies to restore gut health in patients undergoing treatments like chemotherapy. Their approach aims to mitigate treatment-related side effects and improve patient outcomes by utilizing tailored microbial formulations.
Updated 3 months ago
Funding
$1.1M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- MaaT Pharma Microbiota as a Therapy is a French biotech startup focused on developing microbiota-based therapies to restore gut health in patients undergoing treatments like chemotherapy. Their approach aims to mitigate treatment-related side effects and improve patient outcomes by utilizing tailored microbial formulations.